Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Unsure which cash back card is right for you? Explore different options based on your spending habits and find your ideal match.
25,821 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Banks and insurers are watching a quiet 2026 hurricane season closely, warning that storm risk remains a factor for h...
NVIDIA moves to secure critical design software by taking a $2 billion stake in Synopsys, signaling a deeper alignmen...
A big insider move at a major insurer has analysts and traders watching closely. Learn what assured guaranty’s inside...
Trump's proposed holiday could suspend the federal gas tax, offering near-term relief at the pump while creating long...
Elon Musk has floated a colossal Terafab project aimed at dramatically scaling U.S. chip production from a single pla...
Fortune unveils the Crypto 100, a comprehensive ranking of the most influential blockchain-focused firms. The list si...
Morgan Stanley edges toward its 52-week high as earnings strength and wealth inflows support the rally. Analysts weig...
Meta Platforms accelerates its MTIA chip program, signaling a high-stakes race with NVIDIA as hyperscalers push for i...
A bold move by Oracle in the AI data-center space could reshape demand for NVIDIA GPUs. This article explains what th...
Morgan Stanley filed amended SEC registrations for Ethereum and Solana ETFs, proposing a 14-basis-point sponsorship f...
When a star turns a festival stage into a PR moment, money follows — but so do lessons in budgeting and branding. Thi...